NC100100
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
BACKGROUND AND OBJECTIVES
Intravenous myocardial contrast echocardiography is used clinically, but use in small animals has not…
Background and Purpose. NC100100 (Sonazoid™) is a new perfluorocarbon‐based ultrasound contrast agent (UCA) that has not been…
PURPOSE
To evaluate the sonographic appearance of normal prostate vascularity before and after injection of a new ultrasound…
PURPOSE
To evaluate the infusion properties of three ultrasonographic (US) contrast agents and to compare different infusion…
OBJECTIVES
Few intravenous myocardial contrast echocardiography trials have evaluated myocardial perfusion in small animals. The…
BACKGROUND
This study investigated whether the extent of perfusion defect determined by intravenous myocardial contrast…
This study evaluates a new reticuloendothelium specific sonographic contrast agent NC100100 (Sonazoid) for detection of liver VX…
OBJECTIVE To evaluate the clinical and haemodynamic safety of NC100100, a new transpulmonary ultrasound contrast agent intended…
Until recently, the use of contrast agents with 2-dimensional echocardiography has been limited to the detection of intracardiac…